Titel

Merkliste
1 Ergebnisse

Canakinumab with and without pembrolizumab in patients with..:

Garrido, Pilar ; Pujol, Jean-Louis ; Kim, Edward...
info:eu-repo/semantics/altIdentifier/doi/10.2217/fon-2020-1098. , 2021

Link: https://hal.science/hal-03657197

RT Journal
T1 <Title>Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftccsdartic:oai:HAL:hal-03657197v1&Exemplar=1&LAN=DE
				
A1 Garrido, Pilar
A1 Pujol, Jean-Louis
A1 Kim, Edward
A1 Lee, Jay
A1 Tsuboi, Masahiro
A1 Gómez-Rueda, Ana
A1 Benito, Amparo
A1 Moreno, Nicolas
A1 Gorospe, Luis
A1 Dong, Tuochuan
A1 Blin, Cecile
A1 Rodrik-Outmezguine, Vanessa
A1 Passos, Vanessa
A1 Mok, Tony Sk
PB HAL CCSD; Future Medicine
YR 2021
K1 CANOPY
K1 MPR
K1 canakinumab
K1 early stage
K1 immunotherapy
K1 major pathological response
K1 neoadjuvant
K1 non-small-cell lung cancer
K1 resection
K1 surgery
K1 MESH: Adolescent
K1 MESH: Adult
K1 MESH: Antibodies
K1 Monoclonal
K1 Humanized
K1 MESH: Antineoplastic Combined Chemotherapy Protocols
K1 MESH: Carcinoma
K1 Non-Small-Cell Lung
K1 MESH: Clinical Trials
K1 Phase II as Topic
K1 MESH: Female
K1 MESH: Humans
K1 MESH: Interleukin-1beta
K1 MESH: Lung
K1 MESH: Lung Neoplasms
K1 MESH: Male
K1 MESH: Neoadjuvant Therapy
K1 MESH: Neoplasm Staging
K1 MESH: Pneumonectomy
K1 MESH: Programmed Cell Death 1 Receptor
K1 MESH: Randomized Controlled Trials as Topic
K1 MESH: Young Adult
K1 [SDV]Life Sciences [q-bio]
JF info:eu-repo/semantics/altIdentifier/doi/10.2217/fon-2020-1098
LK http://dx.doi.org/https://hal.science/hal-03657197
DO https://hal.science/hal-03657197
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)